CRIS Current Research Information System

FAROLFI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 199
EU - Europa 165
AS - Asia 57
AF - Africa 31
SA - Sud America 3
Totale 455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 198
IT - Italia 56
SG - Singapore 37
SE - Svezia 30
CI - Costa d'Avorio 26
DE - Germania 19
IE - Irlanda 17
GB - Regno Unito 16
BG - Bulgaria 11
CN - Cina 8
IN - India 7
TG - Togo 5
CH - Svizzera 4
ES - Italia 4
BE - Belgio 3
FR - Francia 3
JO - Giordania 3
CL - Cile 2
IR - Iran 2
AT - Austria 1
BR - Brasile 1
GR - Grecia 1
MX - Messico 1
Totale 455
Salva come PNG Salva come JPEG
Città #
Chandler 44
Singapore 34
Abidjan 26
Ashburn 24
Dublin 17
Fairfield 14
Princeton 14
Southend 13
Houston 12
Ann Arbor 11
Sofia 11
Milan 7
Wilmington 7
Cambridge 6
Montescudo 6
Rome 6
Turin 6
Lomé 5
Barcelona 4
Berlin 4
Bologna 4
Des Moines 4
New York 4
Seattle 4
Amman 3
Bern 3
Brussels 3
Florence 3
London 3
Shijiazhuang 3
Boydton 2
Bühl 2
Erchie 2
Figino Serenza 2
Monzuno 2
Mount Pleasant 2
Padova 2
Romainville 2
San Diego 2
Verona 2
Beijing 1
Brusciano 1
Cesena 1
Chicago 1
Frankfurt am Main 1
Gorle 1
Jiaxing 1
Katerini 1
Mexico City 1
Mülheim 1
Parma 1
Redmond 1
Redwood City 1
São Paulo 1
Vienna 1
Washington 1
Woodbridge 1
Totale 342
Salva come PNG Salva come JPEG
Nome #
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 68
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 64
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 64
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 57
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 56
Erratum to “Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life” [Eur J Cancer 69 (2016) 110–118] 40
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice 31
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial 27
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 12
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 10
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 8
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 7
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 7
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients 7
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer 7
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 5
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma 5
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 4
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 4
Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics 3
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures 3
Metastatic bone disease in the era of bone-targeted therapy: Clinical impact 3
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 3
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 3
Psychosocial issues in long-term survivors of testicular cancer 3
Immunotherapy for prostate cancer: Where we are headed 3
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 3
Ipilimumab in advanced melanoma: Reports of long-lasting responses 3
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors 3
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 3
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 3
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 3
Hydroxychloroquine as Prophylaxis for COVID-19: A Review 3
Bevacizumab as maintenance treatment in patients with ovarian cancer: Wait for BRCA testing 2
Sorafenib for the treatment of breast cancer 2
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer 2
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 2
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients 2
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations 2
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? 2
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer 2
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 2
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma 2
null 2
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 2
Immune system and DNA repair defects in ovarian cancer: Implications for locoregional approaches 1
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer 1
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact 1
Totale 552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 17 20 4 0 1 6 4 1 3
2021/2022101 1 0 2 4 6 5 9 9 6 17 23 19
2022/2023179 13 21 5 26 10 18 5 10 43 3 13 12
2023/2024148 8 8 12 2 4 14 6 3 67 3 16 5
2024/202568 63 5 0 0 0 0 0 0 0 0 0 0
Totale 552